Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Bitcoin ETFs Just Had One of Their Worst Weeks on Record, Bleeding $1.2 Billion

Bitcoin ETFs Just Had One of Their Worst Weeks on Record, Bleeding $1.2 Billion

CryptoNewsNetCryptoNewsNet2025/11/22 19:57
By:decrypt.co

Spot Bitcoin exchange-traded funds shed nearly $1.2 billion in assets for the week, the third-highest total in the funds' 22-month history, despite regaining ground on Friday.

November outflows from the 11 funds, which reached a monthly record $3.79 billion on Thursday, hovered at roughly the same total as the previous all-time high—set this February—after Friday's rally, according to data from U.K. asset manager Farside Investors. On Thursday, the ETFs recorded their second highest daily outflows, more than $900 million.

The recent outflows, a rare misstep for the dramatically successful products, have dovetailed with a six-week slump in Bitcoin's price. The largest cryptocurrency by market capitalization plunged to $81,000 early Friday, its lowest mark since early April.

<span></span>

Bitcoin is down about 33% since hitting an all-time high above $126,000 in early October, stung by macroeconomic unrest, including most recently, the decreasing prospects of the U.S. central bank approving a third 2025 interest rate cut, and concerns about an overheated artificial intelligence market.

BlackRock's iShares Bitcoin Trust (IBIT) led this week's hemorrhaging more than $1 billion in outflows, while redemptions from the Grayscale Bitcoin Trust (GBTC) and Fidelity Wise Origin Bitcoin Fund (FBTC) totaled about $172 million and $116 million, respectively.

On Friday, FBTC added $108 million in investments, the best in the category, while the Grayscale Bitcoin Mini Trust ETF (BTC) and GBTC generated $61.5 million and $84.9 million in assets.

The recent outflows have come as a flurry of Solana, XRP and Dogecoin ETFs have started trading over the past month, with additional XRP and Dogecoin products to list next week. The Canary Capital XRP ETF (XRPC) generated $58 million in daily net investments, the most among opening-day totals for all ETFs in 2025, topping the Bitwise Solana Staking ETF's (BSOL) $57 million in its debut, according to Bloomberg data.

BSOL has accumulated more than $660 million in assets in its three-week history, and has yet to record a single day of outflows. The success of these funds has reflected investors' strong appetite for digital asset-based investment products. The U.S. Securities and Exchange Commission is currently weighing dozens of applications for funds tracking individual altcoins, combinations of tokens, and crypto strategies.

In a Friday X post, Bloomberg Senior ETF Analyst Eric Balchunas optimistically noted Bitcoin's historical resilience.

Bitcoin's ability to come back from near death experiences like a super cockroach earned my respect bf I even knew anything about it (tulips were one and done). It also had this special ability to piss off all the right people, which I've been reminded of recently. That said,…

— Eric Balchunas (@EricBalchunas) November 21, 2025

"I get the haters dunking on BTC's slide (enjoy, this is your time), but what I don't get is the obituaries being written," Balchunas wrote. "This asset has survived like half a dozen drawdowns worse than this only to hit [all-time highs] every time. The only other things with that 'Rocky'-esque record are stud stocks like Apple, Amazon, and Florida real estate."

He quipped in a separate tweet: "This asset should [definitely] be treated as HOT SAUCE."

0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!

You may also like

XRP News Today: SEC Approves Altcoin ETFs, Boosting Institutional Investment in Cryptocurrency

- SEC approves multiple XRP/DOGE ETFs from 21Shares, Franklin Templeton, and Grayscale, signaling growing institutional acceptance of altcoins. - 21Shares' TOXR ETF gains automatic approval via CME CF XRP-Dollar tracking, with Coinbase and BNY Mellon handling custody/admin functions. - Franklin Templeton's XRP Trust removes restrictive clauses to accelerate listing, offering regulated exposure without custody risks from ledger forks. - Grayscale expands crypto offerings with XRP/DOGE ETFs on NYSE, joining

Bitget-RWA2025/11/23 20:48
XRP News Today: SEC Approves Altcoin ETFs, Boosting Institutional Investment in Cryptocurrency

Germany's Solar Turning Point: Spotlight on Legislation, Infrastructure, and Ideological Differences

- Germany's SolarPlus Forum 2025 emphasized legislative clarity, funding innovation, and cross-sector collaboration to accelerate solar adoption amid evolving energy policies. - Outdated regulations and permitting hurdles were highlighted as barriers, with calls to align Bundestag reforms with market demands like gas surcharge removal by 2026. - Cement industry growth (5.7% CAGR) and green innovations support infrastructure needs, though energy cost volatility and compliance challenges persist. - Internati

Bitget-RWA2025/11/23 20:48
Germany's Solar Turning Point: Spotlight on Legislation, Infrastructure, and Ideological Differences

Polkadot Latest Updates: ECB Raises Concerns: Cryptocurrency and Stock Market Downturns Resemble Dot-Com Bubble Threats

- ECB warns U.S. equity/crypto corrections threaten stability, urging central banks to retain rate-cut flexibility amid market volatility. - JPMorgan links crypto ETF outflows to retail investor behavior, noting $4B November sales contrast with $96B equity ETF inflows. - U.S. Treasury downplays recession risks, citing 2026 growth optimism despite shutdown impacts and services-driven inflation. - MSCI highlights tech valuation risks akin to dot-com era, while DeFi faces $12B liquidity crisis with 95% capita

Bitget-RWA2025/11/23 20:30
Polkadot Latest Updates: ECB Raises Concerns: Cryptocurrency and Stock Market Downturns Resemble Dot-Com Bubble Threats

Novartis Increases 2030 Growth Projections Despite Analysts' Concerns About Patent Threats

- Novartis raised 2030 sales growth targets to 5-6% annually, driven by high peak sales expectations for oncology drugs Kisqali and Scemblix. - CEO Vas Narasimhan highlighted eight de-risked drugs with $3-10B peak potential, but analysts warned of patent expirations and uncertain pipeline progress beyond 2030. - Shares rose 0.5% post-announcement, while Exact Sciences surged 17% on its $105/share acquisition by Abbott and Samsung Biologics saw a 71% valuation re-rating after spin-off. - J.P. Morgan caution

Bitget-RWA2025/11/23 20:30
Novartis Increases 2030 Growth Projections Despite Analysts' Concerns About Patent Threats